Insulin degludec (addendum to commission A15-10)

Report documents

1. Addendum

   Insulin degludec (addendum to commission A15-10)

   published on

   20.08.2015

   Document type

   PDF document, 269 kB, EN, not accessible

   Download file : Addendum (PDF document, 269 kB, EN, not accessible)

Additional information

Project details

Project no.

A15-26

Commission

Commission awarded on 13.07.2015 by the Federal Joint Committee (GBA).

Report type

Addendum

Status

Commission completed

Department/Division

Drug Assessment

Topic

Digestion, metabolism and hormones

Note

If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.

Connected Projects

1. Dossier assessment

   Insulin degludec (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V (dossier assessment)

   Project no.

   A15-10

   Last updated

   01.06.2015

   Status: Commission completed